ARCHIVES

BioSeek Awarded NIH SBIR For Compound Validation.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants

January 6, 1978

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992